Fragile X syndrome is caused by a mutation in a single gene called FMR1, located on the X chromosome. Specifically, a short DNA sequence (CGG) that normally repeats 5 to 44 times gets expanded to more than 200 repeats, which effectively shuts the gene down and prevents it from making a critical protein needed for brain development.
The CGG Repeat Expansion
Everyone has the FMR1 gene, and everyone has some number of CGG repeats within it. The CDC breaks the ranges into four categories:
- Normal: 5 to 44 repeats
- Intermediate: 45 to 54 repeats
- Premutation: 55 to 200 repeats
- Full mutation: more than 200 repeats
People in the normal and intermediate ranges are unaffected. Those in the premutation range don’t have fragile X syndrome, but they carry a version of the gene that can expand further when passed to the next generation. Once the repeat count crosses 200, the full mutation triggers the syndrome.
How the Gene Gets Silenced
Having more than 200 CGG repeats doesn’t directly damage the gene’s instructions for building its protein. The coding sequence stays intact. Instead, the oversized repeat region triggers an epigenetic shutdown: the body adds chemical tags (methyl groups) to the DNA surrounding the gene, locking it into an inactive state. This happens early, around 10 to 12 weeks of gestation.
In a normal FMR1 gene, there’s a clear boundary between methylated and unmethylated DNA near the gene’s “on switch” (its promoter region). In a full mutation, that boundary disappears. The entire region becomes methylated, and the gene’s chromatin, the packaging structure around DNA, shifts from an open, readable configuration to a tightly wound, closed one. The result is that the gene can no longer be read, and little to no protein is produced despite the underlying code being perfectly fine.
What the Missing Protein Does to the Brain
The protein that FMR1 makes is called FMRP, and it plays a central role in how nerve cells develop, connect, and adapt. FMRP acts as a master regulator of brain development by controlling when and how much protein gets made at synapses, the connection points between neurons. It’s essentially a brake on protein production. When a signal arrives at a synapse, it triggers the creation of new proteins that help strengthen or weaken that connection. FMRP keeps that process in check.
Without FMRP, protein production at synapses runs unchecked. One well-studied consequence involves a specific type of signaling receptor on neurons. Normally, when this receptor is activated, it stimulates local protein production, and FMRP suppresses the excess. In fragile X, the suppression is gone, so the receptor’s effects are amplified far beyond normal levels. This leads to what researchers describe as “hyperexcitability” and excessive, poorly regulated plasticity, meaning the brain’s wiring changes too easily and in disorganized ways.
This imbalance helps explain many features of fragile X syndrome: the learning difficulties, sensory sensitivities, anxiety, and in some cases autism. FMRP is also critical during specific windows of early brain development. Animal studies show it is required for activity-dependent remodeling of synaptic connections during early-use critical periods, the windows when the brain is wiring itself based on experience. Once those windows close, FMRP’s role diminishes, which is why the developmental impact is so significant.
How Fragile X Is Inherited
Fragile X follows an X-linked dominant inheritance pattern. Since the FMR1 gene sits on the X chromosome, the way it’s passed down differs between mothers and fathers, and the effects differ between sons and daughters.
Women have two X chromosomes. If one carries the full mutation, the other may partially compensate, which is why females with fragile X often have milder symptoms. Males have only one X chromosome, so a full mutation means there’s no backup copy. This makes males more likely to be severely affected.
The key to understanding fragile X inheritance is the premutation. A woman carrying a premutation (55 to 200 repeats) may be completely healthy, but when she passes that X chromosome to her children, the unstable repeat region can expand beyond 200 in the egg cell. That means her children are at risk of receiving a full mutation. The larger the mother’s premutation, the higher the chance it will expand. Men with a premutation pass it to all of their daughters (who receive their single X) but none of their sons (who receive the Y chromosome instead). Crucially, the premutation in men does not expand to a full mutation during transmission, so their daughters become carriers but are not affected.
This pattern, where repeats grow larger across generations, is called genetic anticipation. A grandmother with a small premutation might have no symptoms, her daughter might carry a larger premutation, and her grandchild might receive a full mutation and develop the syndrome.
Premutation Carriers Have Their Own Risks
Carrying 55 to 200 CGG repeats doesn’t cause fragile X syndrome, but it isn’t always without consequences. Women with a premutation face an increased risk of primary ovarian insufficiency, a condition where menstrual cycles stop and menopause symptoms begin before age 40. This can also affect fertility.
Older adults with a premutation, both men and women, can develop a separate neurological condition that causes tremors, balance problems, difficulty walking, and memory issues. This typically appears after age 50 and is distinct from fragile X syndrome itself.
Why Severity Varies Between Individuals
Not everyone with a full mutation is affected in the same way, and one major reason is mosaicism. Some individuals have a mix of cells: some carrying the full mutation and others carrying a premutation or even a normal-sized repeat. Others have full mutations with varying degrees of methylation across their cells.
The practical effect is that mosaic individuals may produce some FMRP, even if not at normal levels. Research on males with fragile X found that those with lower methylation levels (under 80%) tended to have higher cognitive abilities, while those with heavier methylation (over 80%) had lower IQ scores and were more likely to also have autism. Higher FMRP production correlated with better outcomes, though the relationship isn’t perfectly predictable. Other genetic and environmental factors play a role too.
How It’s Diagnosed
Fragile X is diagnosed through DNA testing, not by symptoms alone. Two main laboratory techniques are used. The first amplifies the region of DNA containing the CGG repeats to measure how many are present. This method works well for normal, intermediate, and premutation-sized repeats but can struggle with very large full mutations because the expanded DNA is harder to copy in the lab.
The second technique provides a broader view. It can detect repeats across all size ranges and simultaneously assess whether the gene is methylated, giving a picture of both the mutation size and whether the gene is actually turned off. In practice, both methods are often used together to get a complete diagnosis. Testing can also identify premutation carriers in family members who want to understand their risk of having affected children.